LONDON, Jan. 2, 2013 /PRNewswire/ -- The promise of cost and clinical benefits are spurring the penetration of imaging modalities in cardiac applications. While demographics are favouring market growth, cardiac imaging device manufacturers will have to focus on innovative, patient-friendly products that promote greater safety and easier operability.
New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Global Trends in Medical Imaging – Cardiology Applications, finds that there has been a shift in the adoption pattern for imaging modalities. With the markets in North America and Europe mostly saturated, the largest revenue share is now generated by emerging economies like China, India, Russia and Brazil. The research covers 4 diagnostic modalities for cardiac applications: cardiac computed tomography (CT), cardiovascular magnetic resonance imaging (MRI), echocardiography and interventional cardiology.
Demographics are playing a key role in the market. An aging population has been the foremost driver in the healthcare market. The rising incidence of cardiovascular diseases is expanding the patient pool, while resulting in escalating demand for equipment and software that enable better diagnoses.
This is highlighting the need for technologically advanced medical imaging modalities. However, the lack of consensus on which imaging modality is most appropriate for a particular cardiac ailment has affected uptake levels.
"All the modalities are here to stay," notes Frost & Sullivan Senior Research Analyst Akanksha Joshi. "What is less clear is which of these modalities is most appropriate for which patients and in which clinical scenarios in terms of diagnostic accuracy and, even more importantly, in terms of patient outcome and cost-effectiveness."
During product development and marketing, therefore, manufacturers need to consider the fact that the choice of modality used is based on the preference of the cardiologist or radiologist. Moreover, they need to account for preference patterns for a particular modality showing regional variations.
The adoption of advanced modalities is slower in the cardiology space, compared to other segments. This is partly due to the lack of skilled healthcare professionals who can effectively use the new devices.
"It is therefore critical for manufacturers to provide innovative, accurate, reliable and patient-friendly equipment," advises Joshi. "Such endeavours will assuage the apprehensions of the medical community in using new technology."
If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at email@example.com
Global Trends in Medical Imaging–Cardiology Applications is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: European Operating Room Solutions Market, European Market for Computed Tomography and European Molecular Imaging Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
SOURCE Frost & Sullivan